CIBC Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

CIBC Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,121	Closed	-$1.18M	–	974
2016 Q2	$1.18M	Sell	8,121 -9,625	-54%	-$1.36M	0.01%	502
2016 Q1	$2.54M	Sell	17,746 -742	-4%	-$105K	0.02%	311
2015 Q4	$2.86M	Sell	18,488 -3,455	-16%	-$504K	0.02%	284
2015 Q3	$3.13M	Sell	21,943 -10,297	-32%	-$1.44M	0.03%	256
2015 Q2	$4.63M	Sell	32,240 -560	-2%	-$79.9K	0.03%	218
2015 Q1	$4.63M	Sell	32,800 -1,790	-5%	-$276K	0.03%	210
2014 Q4	$5.13M	Buy	34,590 +5,600	+19%	+$823K	0.03%	187
2014 Q3	$4.46M	Buy	+28,990	New	+$4.36M	0.03%	226

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC Asset Management's TARO Position: Q3 2016 in Review

CIBC Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2016, closing a stake of 8,121 shares — an estimated $1.18M sold.

CIBC Asset Management first reported a position in TARO in Q3 2014 and held it in 8 quarters. The position peaked at $5.13M in Q4 2014. 162 funds tracked by Wall St. Rank hold TARO as of Q3 2016.

CIBC Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2016 after selling out during the quarter.
CIBC Asset Management sold 8,121 Taro Pharmaceutical Industries Ltd. shares in Q3 2016, an estimated $1.18M.
CIBC Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and held it in 8 quarters.
CIBC Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $5.13M in Q4 2014.
162 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2016.

Based on CIBC Asset Management's 13F filing for Q3 2016, filed 19 Oct 2016.